Ortivus

Ortivus FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Ortivus (ORTI B.ST) as of Nov 1, 2026 is 230.73 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 39.28 % — a change of 487.39% (higher).

FCF Conversion

230.73 %

YoY

487.39%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Ortivus is 2025 230.73 % . FCF Conversion Rate (FCF/EBITDA) of Ortivus was 2024 39.28 % . It decreases by 487.39% higher compared to the previous year.

The Ortivus FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
9.92 SEK
Jan 1, 2019
25.73 SEK
Jan 1, 2020
140.28 SEK
Jan 1, 2021
11.64 SEK
Jan 1, 2022
-220.15 SEK
Jan 1, 2023
60.65 SEK
Jan 1, 2024
39.28 SEK
Jan 1, 2025
230.73 SEK
The Ortivus FCF Conversion history
YEARFCF ConversionYoY
230.73 %+487.39%
39.28 %-35.23%
60.65 %-127.55%
-220.15 %-1,991.57%
11.64 %-91.70%
140.28 %+445.13%
25.73 %+159.49%
9.92 %-90.60%
105.54 %-252.75%
-69.09 %-134.96%
197.62 %-36.38%
310.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ortivus stock

FCF Conversion Rate (FCF/EBITDA) of Ortivus is 230.73 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Ortivus changed from 39.28 % to 230.73 %, representing a 487.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Ortivus since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Ortivus with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ortivus

All Key Metrics — Ortivus